The debate on over-medicalization: Are we pathologizing normal human struggles?

In recent years, the line between clinical depression and everyday emotional distress has become increasingly blurred. More general practitioners and mental health professionals are raising concerns that normal experiences of sadness, stress, and hardship are being misclassified as clinical disorders, leading to an over-reliance on antidepressants and other psychotropic medications.

A growing body of research suggests that mental health diagnoses have expanded beyond their original intent. The criteria for Major Depressive Disorder (MDD), as outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), include symptoms such as fatigue, changes in sleep patterns, and difficulty concentrating — many of which can also be triggered by life events such as job loss, grief, or financial hardship. Some experts argue that instead of allowing natural emotional processes to unfold, there is a tendency to pathologize these responses, leading to unnecessary medical intervention.

A 2023 study published in The Lancet Psychiatry found that nearly sixty percent of individuals diagnosed with depression did not meet the threshold for moderate to severe depressive disorder. This raises serious ethical concerns about the potential for unnecessary pharmaceutical treatments and the minimization of non-medical interventions such as therapy, lifestyle changes, and social support.

The influence of pharmaceutical companies in shaping public and clinical perceptions of mental health cannot be ignored. Antidepressant prescriptions have increased dramatically in the last two decades, with the Centers for Disease Control and Prevention (CDC) reporting a thirty-five percent rise in their use among adults between 2000 and 2020. While medication is a crucial tool for individuals with severe depression, its widespread prescription for mild or situational distress suggests a broader cultural shift toward viewing all emotional suffering as a disorder in need of medication.

Many researchers and clinicians advocate for a more precise approach to mental health, one that distinguishes between transient distress and clinical disorders. Evidence-based strategies such as cognitive-behavioral therapy (CBT), mindfulness practices, social connection, and structured problem-solving have been shown to be highly effective in addressing stress, anxiety, and mild depression without medical intervention.

A recent comprehensive study analyzing multiple research findings in JAMA Psychiatry found that individuals with mild to moderate depression often benefit more from therapy and lifestyle modifications than from medication alone. This underscores the importance of comprehensive assessments and individualized treatment plans.

Over-medicalization does not mean mental illness is not real or that medication is unnecessary. Instead, it calls for discernment in differentiating between normal emotional fluctuations and clinically significant mental health conditions. By promoting accurate diagnosis, responsible prescribing, and a broader acceptance of natural emotional experiences, we can cultivate a healthier and more realistic approach to mental well-being.

As mental health awareness continues to grow, it is crucial to ensure that increased recognition does not come at the cost of over-pathologizing human struggles. Thoughtful, research-driven approaches will help maintain a realistic perspective, ensuring that individuals receive the right kind of support at the right time.

Scotty